We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+16.49%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$838M
AUM Growth
+$41.4M
(+5.2%)
Cap. Flow
-$59.8M
Cap. Flow
% of AUM
-7.14%
Top 10 Holdings %
Top 10 Hldgs %
41.9%
Holding
74
New
19
Increased
15
Reduced
20
Closed
19
Top Buys
| 1 |
Agilent Technologies
A
|
+$44.5M |
| 2 |
Bausch Health
BHC
|
+$40.6M |
| 3 |
CSLT
CASTLIGHT HEALTH, INC.
CSLT
|
+$34.3M |
| 4 |
RAD
Rite Aid Corporation
RAD
|
+$23.2M |
| 5 |
HCA Healthcare
HCA
|
+$22.6M |
Top Sells
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$72.5M |
| 2 |
Gilead Sciences
GILD
|
+$48.6M |
| 3 |
Zimmer Biomet
ZBH
|
+$34.3M |
| 4 |
CELG
Celgene Corp
CELG
|
+$30.9M |
| 5 |
AstraZeneca
AZN
|
+$30.3M |
Sector Composition
| 1 | Healthcare | 80.49% |
| 2 | Technology | 2.82% |
| 3 | Communication Services | 1.03% |
| 4 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $50.7M | 6.06% |
246,398
+74,158
| +43% | +$14.7M |
|
|
2
HCA Healthcare
HCA
$83.9B
| $45.8M | 5.47% |
872,589
+453,489
| +108% | +$22.6M |
|
|
3
Agilent Technologies
A
$38B
| $43.2M | 5.16% |
+1,080,646
| New | +$44.5M |
|
|
4
Bausch Health
BHC
$1.82B
| $39.2M | 4.68% |
+297,136
| New | +$40.6M |
|
|
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
| $35.5M | 4.24% |
513,198
-59,072
| -10% | -$4.34M |
|
6
Tenet Healthcare
THC
$16.6B
| $33.8M | 4.04% |
789,562
+328,160
| +71% | +$14.5M |
|
7
Globus Medical
GMED
$10.6B
| $28.3M | 3.37% |
1,062,952
-23,685
| -2% | -$563K |
|
|
HTWR
8
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $27.4M | 3.27% |
291,974
+69,951
| +32% | +$6.81M |
|
|
RAD
9
DELISTED
Rite Aid Corporation
RAD
| $23.8M | 2.85% |
+190,090
| New | +$23.2M |
|
|
TVTY
10
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $23.2M | 2.77% |
1,354,832
+508,419
| +60% | +$7.83M |
|
|
ARRY
11
DELISTED
Array Biopharma Inc
ARRY
| $22.9M | 2.74% |
4,882,930
+422,242
| +9% | +$2.12M |
|
12
Bristol-Myers Squibb
BMY
$119B
| $21.7M | 2.6% |
418,500
+17,630
| +4% | +$938K |
|
13
Insulet
PODD
$11.2B
| $21.7M | 2.59% |
457,048
+94,012
| +26% | +$4.16M |
|
14
Prothena Corp
PRTA
$448M
| $21.4M | 2.56% |
559,611
+550,511
| +6,050% | +$17.7M |
|
|
CSLT
15
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $20.8M | 2.49% |
+1,184,347
| New | +$34.3M |
|
|
CMRX
16
DELISTED
Chimerix, Inc.
CMRX
| $20.4M | 2.44% |
895,006
+148,601
| +20% | +$3M |
|
|
NUVA
17
DELISTED
NuVasive, Inc.
NUVA
| $20M | 2.39% |
521,301
-29,613
| -5% | -$1.09M |
|
18
Jazz Pharmaceuticals
JAZZ
$15.1B
| $19.8M | 2.37% |
142,886
-39,675
| -22% | -$5.97M |
|
|
GWPH
19
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $19.2M | 2.29% |
323,583
-36,394
| -10% | -$2.16M |
|
|
ITCI
20
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $18.2M | 2.17% |
+1,001,060
| New | +$18.1M |
|
21
Puma Biotechnology
PBYI
$425M
| $17.9M | 2.14% |
172,092
-58,581
| -25% | -$6.89M |
|
|
KYTH
22
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $17.6M | 2.1% |
443,326
-114,435
| -21% | -$5.12M |
|
|
FOLD
23
DELISTED
Amicus Therapeutics
FOLD
| $17.6M | 2.1% |
8,496,538
-151,549
| -2% | -$379K |
|
|
ICPT
24
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $16.9M | 2.01% |
51,113
-214,836
| -81% | -$72.5M |
|
25
Celldex Therapeutics
CLDX
$3.01B
| $15.3M | 1.82% |
57,596
+31,066
| +117% | +$11.9M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO